Back
Evogene Ltd. 10K Form
Sell
21
EVGN
Evogene Ltd.
Last Price:
$0.94
Seasonality Move:
-0.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EVGN News And Ratings
See the #1 stock for the next 7 days that we like better than EVGN
EVGN Financial Statistics
Sales & Book Value
| Annual Sales: | $8.5M |
|---|---|
| Cash Flow: | $-3.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.13 |
| Price / Book: | 7.41 |
Profitability
| EPS (TTM): | -0.49080 |
|---|---|
| Net Income (TTM): | $-9.3M |
| Gross Margin: | $3.4M |
| Return on Equity: | -66.95% |
| Return on Assets: | -26.54% |
Evogene Ltd. Earnings Forecast
Key Evogene Ltd. Financial Ratios
-
The Gross Profit Margin over the past 18 years for EVGN is 39.81%.
-
The Selling, General & Administrative Expenses for EVGN have been equal to 127.67% of Gross Profit Margin.
-
The Research & Development expenses have been 167.50% of Revenue.
-
The Net Earning history of EVGN is -212.13% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 9 years.
Evogene Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EVGN |
| CUSIP: | M4119S |
| Website: | evogene.com |
Debt
| Debt-to-Equity Ratio: | 2.21 |
|---|---|
| Current Ratio: | 4.92 |
| Quick Ratio: | 4.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
EVGN Technical Analysis vs Fundamental Analysis
Sell
21
Evogene Ltd. (EVGN)
is a Sell
Is Evogene Ltd. a Buy or a Sell?
-
Evogene Ltd. stock is rated a SellThe current Evogene Ltd. [EVGN] share price is $0.97. The Score for EVGN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.